Bayer gains first Aliqopa approval in follicular lymphomaBayer has gained FDA accelerated approval for its follicular lymphoma drug Aliqopa (copanlisib), giving it entry to the Share XBayer gains first Aliqopa approval in follicular lymphomahttps://pharmaphorum.com/news/aliqopa-follicular-lymphoma/
